Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Recently Receives $1.5M in NIH Grants

NEW YORK, Dec. 29 (GenomeWeb News) - Illumina has won around $1.5 million through a pair of recent grants from the US National Institutes of Health, according to the NIH.


The grants, which the NIH said are effective as of Dec. 26, but that Illumina had not previously disclosed, include:

  • $506,021 for a high-throughput methylation-profiling system;
  • $194,951 for research into allelic expression-monitoring by array-based genotyping;
  • $603,106 to develop a protease substrate array; and
  • $169,877 to develop an allergy peptide array.
The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.